E Bernard
-
- Antibiotic Use and Resistance 6
- Molecular Medicine top 5%
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 16
- Clinical Biochemistry top 5%
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 9
-
- Orthopedic Infections and Treatments 10
- Infectious Diseases and Tuberculosis 8
-
- Infective Endocarditis Diagnosis and Management 7
- Pneumonia and Respiratory Infections 5
-
- Streptococcal Infections and Treatments 5
E Bernard
51 papers receiving 527 citations
Peers
Comparison fields: 5 of 72
- Applied Microbiology and Biotechnology 55
- Molecular Medicine 95
- Pharmacology 204
- Clinical Biochemistry 72
- Infectious Diseases 180
Countries citing papers authored by E Bernard
This map shows the geographic impact of E Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bernard more than expected).
Fields of papers citing papers by E Bernard
This network shows the impact of papers produced by E Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bernard. The network helps show where E Bernard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E Bernard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 11 | |
| 2 | 2015 | 12 | |
| 3 | 2013 | 6 | |
| 4 | 2011 | 25 | |
| 5 | 2010 | 5 | |
| 6 | 2003 | 13 | |
| 7 | 2001 | 5 | |
| 8 | 1998 | 12 | |
| 9 | 1997 | 12 | |
| 10 | 1994 | 13 | |
| 11 | 1993 | 13 | |
| 12 | 1992 | 5 | |
| 13 | 1990 | 17 | |
| 14 | [Kinetics of pefloxacin diffusion in human bone tissue following a single infusion of 800 mg. Evaluation of an extraction technic using chloroform]. | 1988 | 4 |
| 15 | Cinétique de la diffusion de la péfloxacine dans le tissu osseux humain après perfusion unique de 800 mg. Evaluation de la technique d'extraction par le chloroforme. | 1988 | 2 |
| 16 | Effet de la rifampicine sur la pharmacocinétique de la doxycycline. | 1987 | 4 |
| 17 | Facteurs discriminants du risque infectieux en chirurgie digestive réglée. Essai à propos de trois cent huit cas. | 1982 | 1 |
| 18 | Brucellose aiguë avec thrombopénie et anticorps cytotoxiques. | 1982 | 1 |
| 19 | &'* CAS DE POLYCHIMIOTHérapie prolongée dans des cancers avancés (surtout broncho-pulmonaires). Modalités et résultats. | 1968 | 1 |
| 20 | Note préliminaire sur la vaccination intensive par voie buccale chez le nourrisson et l'enfant du premier age; le B. C. G. test d'accompagnement. | 1954 | 0 |
About E Bernard
E Bernard is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 53 papers that have together received 556 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Orthopedic Infections and Treatments (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Infectious Diseases and Tuberculosis (8 papers), Infective Endocarditis Diagnosis and Management (7 papers), Antibiotic Use and Resistance (6 papers), Streptococcal Infections and Treatments (5 papers) and Pneumonia and Respiratory Infections (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (55 citations), Molecular Medicine (95 citations) and Pharmacology (204 citations). E Bernard has collaborated with scholars based in France, Germany and Vietnam. Frequent co-authors include P. Dellamonica, R. Garraffo, P Lapalus, Éric Cua, H Drugeon, C. Pulcini, J. Durant, V. Mondain, Pierre‐Marie Roger and H. Drugeon. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Drugs, Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.